AKTX
Akari Therapeutics
AKTX
AKTX
6 hedge funds and large institutions have $269K invested in Akari Therapeutics in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-4
Holders Change %
-40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VKH
Virtu KCG Holdings
New York
|
+$26K |
2 |
Citadel Advisors
Miami,
Florida
|
+$22K |
3 |
UBS Group
Zurich,
Switzerland
|
+$1K |
4 |
Wells Fargo
San Francisco,
California
|
+$1K |
5 |
Citigroup
New York
|
+$500 |
Top Sellers
1 |
![]()
Franklin Resources
San Mateo,
California
|
-$3.37M |
2 |
BBA
Baker Bros. Advisors
New York
|
-$3.24M |
3 |
BC
Broadfin Capital
New York
|
-$2.26M |
4 |
SCM
Sio Capital Management
New York
|
-$881K |
5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$211K |